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Malignant melanoma (MM) is the most aggressive form of skin cancer. Adult anthropometry inﬂuences MM de-
velopment; however, associations between childhood body size and future melanomagenesis are largely un-
known. We investigated whether height, body mass index (BMI; weight (kg)/height (m)2), and body surface area
(BSA) at ages 7–13 years and birth weight are associated with adult MM. Data from the Copenhagen School
Health Records Register, containing annual height and weight measurements of 372,636 Danish children born in
1930–1989, were linked with the Danish Cancer Registry. Cox regression analyses were performed. During
follow-up, 2,329 MM cases occurred. Height at ages 7–13 years was signiﬁcantly associated with MM, even after
BMI and BSA adjustments. No signiﬁcant BMI-MM or BSA-MM associations were detected when adjusting for
height. Children who were persistently tall at both age 7 years and age 13 years had a signiﬁcantly increased MM
risk compared with children who grew taller between those ages. Birth weight was positively associated with MM.
We conclude that associations between body size and MM originate early in life and are driven largely by height
and birth weight, without any comparable inﬂuence of BMI or BSA. Melanoma transformation is unlikely to be due
to height per se; however, height-regulating processes in childhood present new areas for mechanistic explora-
tions of this disease.
birth weight; body height; body mass index; body surface area; child; melanoma
Abbreviations: BMI, body mass index; BSA, body surface area; CI, conﬁdence interval; CSHRR, Copenhagen School Health
Records Register; HR, hazard ratio; MM, malignant melanoma.
During the last several decades, the incidence of malignant
melanoma (MM) has dramatically increased. In 2012, ap-
proximately 232,000 new cases were diagnosed worldwide
(1). In contrast with many other human malignancies, the in-
cidence rate for MM starts to increase during adolescence (2).
A genetic predisposition, melanocytic nevi, fair skin pigmen-
tation, and exposure to ultraviolet radiation are known risk
factors for melanoma development (melanomagenesis) (3, 4).
However, the underlying processes responsible for a predis-
position to MM are multifaceted and not fully understood;
they conceivably involve additional etiological factors.
Childhood is a critical period of growth in which the skin
expands widely to accommodate the growing child. The
proliferation rate of epidermal melanocytes changes with de-
velopment and peaks during childhood and adolescence (5).
Notably, murine skin grafts from newborns are more prone
to develop melanoma when exposed to ultraviolet radiation
compared with skin grafts from adults (6), indicating that
preadult life is a vulnerable period of particular signiﬁcance
in predisposing individuals to future melanomagenesis. Ac-
cordingly, several studies have examined whether birth
weight is linked to MM risk, and some, but not all, have
found positive associations (7–11). At the other end of the
life span, several studies have investigated whether adult
height, body mass index (BMI), and body surface area
(BSA) are associated with MM risk (12–21). Generally,
adult height and BSA are positively associated with MM,
whereas results for BMI are equivocal. Despite these stud-
ies, there is a gap in knowledge as to whether the association
between body size and MM risk originates in childhood.
Therefore, we investigated whether childhood height, BMI,
BSA, or birth weight was associated with an increased risk
of cutaneous and invasive forms of MM in a large cohort of
Danish children.
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METHODS
Cohort
The Copenhagen School Health Records Register (CSHRR)
contains computerized health information on 372,636 Danish
children who attended public and private schools in the Co-
penhagen municipality and were born during the period
1930–1989 (22). Each child had an individual school health
card that included information on the child’s name and date of
birth. Furthermore, it included information on annual height
and weight measurements from the ages of 7 years to 13 years
which were taken by physicians and nurses using standardized
procedures.
During the health examination, weight and height mea-
surements were conducted without shoes and while the chil-
dren were either naked or wearing underwear; only after
1973 was light clothing allowed (22). After 1983, body size
measurements were only available at ages corresponding to
school entry and exit due to procedural changes in the muni-
cipality. Children were measured more frequently if they
had special health conditions or needs. From the year 1942
(year of birth 1936) onwards, information on birth weight
is available. Birth weight was either parentally reported or
copied from the child’s health book.
BMI was calculated as weight (kilograms) divided by the
square of height (meters), and BSA was calculated according
to the formula (weight (kg)0.5378 × height (cm)0.3964 × 0.024265)
as described by Haycock et al. (23). BMI and BSA values
were transformed to z scores based on age- and sex-
speciﬁc reference values, whereas height data were trans-
formed to z scores based on age-, sex- and birth cohort-
speciﬁc (5-year interval) reference values. For BMI, the
reference population was selected from a period when the
obesity rate was low and stable (children born from 1955
to 1960) (24). The BMI, BSA, and height z scores were
computed using the lambda mu sigma method (25). Height
and BMI z scores were directly used if the measurements
were taken exactly on the child’s birthday. Otherwise, if 2
measurements existed within a period of ±12 months, the z
scores were interpolated to the child’s age in whole years
(i.e., age 7, 8, …, 13 years) or extrapolated if only 1 mea-
surement was available.
On April 2, 1968, the Danish Civil Registration System
introduced unique personal identiﬁcation numbers to all
living citizens of Denmark and those born thereafter (26).
These identiﬁcation numbers were recorded on the health
cards and retrieved for children in school prior to this
time on the basis of their name, date of birth, and sex. A
conservative approach was used to ensure the validity of
the retrieved numbers, and as a result they were identiﬁed
for 88% of all children (22). The identiﬁcation numbers
enabled linkage at the individual level to the Danish Can-
cer Registry for follow-up. The Danish Cancer Registry
was founded in 1942 and contains records of the inci-
dence of malignant and selected benign tumors in the Dan-
ish population (27). Notably, 89% of the cancers are
morphologically conﬁrmed, ensuring a high validity of the
registry (27). The diagnosis of cutaneous MM was deﬁned
according to the International Classiﬁcation of Diseases,
Seventh Revision (code 190) and the International Classiﬁca-
tion of Diseases, Tenth Revision (code C43). Information on
vital status was obtained through linkage to the Vital Statis-
tics Register (26).
Study population
To be eligible for this study, individuals needed an identi-
ﬁcation number (to enable follow-up) and needed to be at
least 15 years of age. Accordingly, the follow-up period was
initiated in 1968 when individuals received this number or
at age 15 years, depending on which occurred last. Ad-
ditionally, follow-up ended on the date of an MM diagno-
sis, emigration, death, or loss to follow-up or on December
31, 2012 (date of the last available update from the Danish
Cancer Registry), whichever came ﬁrst. Of the total num-
ber of CSHRR individuals (n = 372,636), we excluded
42,668 individuals without identiﬁcation numbers (e.g.,
children for whom numbers could not be retrieved), 2,709
individuals who emigrated, died, or were lost to follow-up
prior to age 15 years or April 2, 1968, 4 individuals with a
missing date of MM diagnosis, 19 cases who were diag-
nosed with MM before the age of 15 years or April 2, 1968,
6,143 individuals with missing height or weight measure-
ments, and 9 individuals with outlying height or BMI values
(z score <−4.5 or >4.5) at all ages. This resulted in a cohort
of 321,084 eligible participants (162,638 men and 158,446 wom-
en) (see Web Figure 1, available at http://aje.oxfordjournals.
org/). For the growth analyses of height, only individuals
who had measurements at both age 7 years and age 13 years
were included (total = 258,594; 129,876 men and 128,718
women). Because children rarely change by ±1 z score in
height, we present the results for an “average” child with
a height z score of 0, a “tall” child with a z score of 0.5, and
a “persistently tall” child with a z score of 0.5 at both age
7 years and age 13 years.
In the subanalysis of birth weight, the further eligibility cri-
teria of being born in 1936 or onwards and having a birth weight
of 2.0–5.5 kg were applied. This resulted in a study population
of 244,847 individuals (124,999 men and 119,848 women)
(Web Figure 2).
Statistical methods
Cox proportional hazards regression analyses were con-
ducted to analyze the associations between height or BMI or
BSA z scores at each age from 7 to 13 years and the risk of
adult MM. The association between birth weight (kg) and the
future risk of MM was investigated using the same approach.
Age was the underlying time metric, and all analyses were
stratiﬁed by birth cohort (5-year strata: 1930–1934 …
1980–1984 and 1985–1989). Because height and BMI
were weakly correlated (rage7 = 0.19, rage13 = 0.29), the
analyses for the explanatory variables were repeated
using mutual adjustment (i.e., with the height models ad-
justing for BMI or BSA, the BMI models adjusting for
height, and the BSA models adjusting for height). Fur-
thermore, we found that height and BSA were strongly
correlated (rage7 = 0.83, rage13 = 0.79), so we repeated
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the same adjustments. Additionally, using Cox proportional
hazards regression, we investigated the associations between
different growth patterns in height z scores from ages 7 to 13
years and MM. Departures from linearity were assessed by
testing against a restricted cubic spline with 5 knots placed at
the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. The pro-
portional hazards assumptions were checked by including a
time-varying covariate in the Cox regression model.
Using a likelihood ratio test, potential interactions be-
tween birth cohort and associations between height, BMI,
BSA, or birth weight and the risk of developing MM were
investigated in 5-year intervals up to 1975. Due to a low
number of cases, the birth years from 1975 to 1989 were
combined into 1 category (1930–1934 … 1970–1974 and
1975–1989). Furthermore, potential interactions between
sex and height, BMI, BSA, or birth weight and the risk of
MM were also investigated (using a likelihood ratio test).
Overall, no departures from linearity (all P’s > 0.14), vio-
lations of the proportional hazards assumption, or differ-
ences in the associations by birth cohort (all P’s > 0.12)
were detected. None of the associations differed signiﬁ-
cantly by sex; thus, all analyses were stratiﬁed by sex.
Since sex-speciﬁc estimates may be of interest, they are
presented in Web Tables 1–4. The statistical analyses were
conducted using Stata, version 12.1 (StataCorp LP, Col-
lege Station, Texas). The study was approved by the Da-
nish Data Protection Agency. In accordance with Danish
law, informed consent is not required for purely register-
based studies of preexisting information.
RESULTS
During approximately 11 million person-years of follow-
up, 2,329 MM cases (1,057 men and 1,272 women) were
identiﬁed. The age span for MM diagnosis was broad, rang-
ing from 16 years to 82 years, with a median age of 58 years
for men (5th–95th percentile range, 33–75) and 52 years for
women (5th–95th percentile range, 28–73). Between ages 7
and 13 years, median height, BMI, and BSA values increased
from approximately 122 cm to 156 cm, from 15 to 18, and
from 0.87 m2 to 1.38 m2, respectively (Table 1).
We investigated associations between childhood height at
the ages of 7–13 years and the risk of MM and found signiﬁ-
cant and positive associations between height at all ages and
MM. At ages 7 and 13 years, the hazard ratios per height z
score were 1.21 (95% conﬁdence interval (CI): 1.16, 1.26)
and 1.20 (95% CI: 1.15, 1.25), respectively (Figure 1, Web
Table 5). One z-score increment in height corresponded to
approximately 5.1 cm at age 7 years and 8 cm at age 13 years
in boys and approximately 5.2 cm at age 7 years and 6.9 cm
at age 13 years in girls. The values were larger at age 13 years
due to greater variation in height at this age. Similar results
were found at ages 8–12 years (Figure 1, Web Table 5). Fur-
thermore, when the associations were adjusted for childhood
BMI or BSA, the associations between childhood height and
MM remained virtually unchanged (Figure 1, Web Table 5),
indicating that the height-MM association was independent
of childhood BMI and BSA.
The investigation of associations between childhood BMI
or BSA at ages 7–13 years and the diagnosis of MM in adult-
hood revealed that for BMI the hazard ratios were small and
in the positive direction but generally not statistically signiﬁ-
cant, whereas the associations between BSA and MM were
positively signiﬁcant (Table 2). The results were similar at all
ages. Notably, when these results were adjusted for childhood
height, the hazard ratios were attenuated for both BMI and
BSA, and all became nonsigniﬁcant (Table 2).
Furthermore, we also investigated whether growth in
height between the ages of 7 and 13 years was associated
with MM. These analyses included 2,022 MM cases (910
men and 1,112 women) who had height measurements avail-
able at both ages. Most children remained in their growth
trajectory, and 32% of the children had height changes of at
least ±0.5 z score between these ages. We found that com-
pared with a child who had average height at both age 7 years
and age 13 years (reference, z score = 0), a child who had an
average height at age 7 years but was taller at age 13 years (z
score = 0.5, corresponding to approximately 4 cm greater
growth in boys and girls) did not have a signiﬁcantly higher
risk of MM (P = 0.29) (Table 3). However, compared with
the reference child, signiﬁcantly increased risks of MM were
observed for a child who was taller at age 7 years but of aver-
age height at age 13 years (P = 0.001) and for a child who
was persistently taller at ages 7 and 13 years (P < 0.001)
(Table 3). Further, compared with a child who was of aver-
age height at age 7 years but taller at age 13 years, a child
who was persistently taller at ages 7 and 13 years had a sig-
niﬁcantly higher risk of MM (hazard ratio = 1.08, 95% CI:
1.03, 1.13; P = 0.001).
In the subanalysis on birth weight, 1,682 individuals (755
men and 927 women) were diagnosed with MM. Birth
weight was positively and signiﬁcantly associated with adult
MM, with a hazard ratio of 1.13 (95% CI: 1.03, 1.23) per kg
of birth weight. Sex-speciﬁc estimates are presented in Web
Table 4. No interactions between birth weight and height,
BMI, or BSA were detected (all P’s > 0.20).
DISCUSSION
In this study, we found that greater childhood height at the
ages of 7–13 years was signiﬁcantly associated with an in-
creased risk of MM in adulthood. Moreover, the height-MM
association remained virtually unchanged after adjustment
for BMI or BSA, indicating that the association works inde-
pendently of BMI and BSA in children. For childhood BMI,
we detected only small positive associations that were mostly
not statistically signiﬁcant, and after adjustment for height
they disappeared altogether. Furthermore, the associations
between childhood BSA and MM were statistically signiﬁ-
cant; however, they were attenuated after adjustment for
height. Collectively, these results suggest that height plays
a more dominant role than BMI and BSA in MM develop-
ment. Growth during childhood was also associated with
MM risk—children who were persistently tall had a higher
risk of MM in adulthood than children who grew tall between
ages 7 and 13 years. Finally, we observed that birth weight was
positively and signiﬁcantly associated with MM development.
Am J Epidemiol. 2017;185(8):673–680
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The associations between body size and MM develop-
ment have been investigated in various adult populations,
but the results have been equivocal. Several studies have
found associations between greater adult height and MM
(12, 13, 16–20), and generally height displays the strongest
association with MM as compared with cancers at other ana-
tomical sites (17–20). Similarly, although there are discrep-
ancies in the literature (12–16, 28, 29), BSA is generally
positively associated with MM development. However, in
agreement with our results, the lack of analyses adjusting
BSA for height could result in incorrect identiﬁcation of
BSA as an MM risk factor, even though it is in fact the
height parameter of BSA that is the main driver of the posi-
tive association with MM risk. In regard to the BMI-MM as-
sociation, results of previous studies contradict each other
(12–16, 21, 28, 30), making it difﬁcult to disentangle
whether BMI is a risk factor for melanomagenesis. Never-
theless, sex-speciﬁc differences have been reported, with
BMI being signiﬁcantly associated with MM development
in men but not in women, conceivably resulting from different
sunbathing habits in obese women (12). However, proposed
biological mechanisms are lacking.
Our height-MM results derive from measurements taken
from children, making direct comparisons with adult studies
challenging, and only a few studies have been conducted in
adolescents. In agreement with our identiﬁed height-MM as-
sociation, a study of Israeli adolescents (ages 16–19 years)
found that greater height was a risk factor for MM (31).
Additionally, BSA was also found to be associated with
MM risk (31). In contrast, in a study of American agricul-
tural workers which used self-reported heights and weights
upon enrollment plus recalled weight at age 20 years, Dennis
et al. (32) did not ﬁnd associations between height and MM.
However, they found that BMI and BSA at age 20 years
were positively associated with MM (32). Different ﬁndings
for the height-MM associations may be due to ethnicity,
population size, and the inaccuracy of self-reported and re-
called measurements.
Table 1. Median Values for Height, Body Mass Index, and Body Surface Area for 321,084 Boys and Girls at Each Age From Ages 7 to 13 Years,
Copenhagen, Denmark, 1968–2012a
Characteristic
and Age, years
Boys Girls
No. of Childrenb Median 5th Percentile 95th Percentile No. of Childrenb Median 5th Percentile 95th Percentile
Height, cm
7 151,893 122.6 114.0 131.2 147,998 121.7 113.0 130.4
8 153,742 127.9 118.9 137.0 149,777 126.9 117.9 136.0
9 147,874 133.1 123.8 142.9 144,778 132.1 122.7 142.0
10 143,832 138.1 128.4 148.4 141,261 137.2 127.3 148.0
11 142,678 142.9 132.8 153.8 140,371 142.9 132.0 154.8
12 141,210 147.7 137.0 159.8 139,313 149.3 137.1 161.7
13 138,607 153.5 141.5 167.6 137,413 155.5 143.0 167.0
Body mass indexc
7 151,893 15.4 13.8 17.7 147,998 15.3 13.5 18.0
8 153,742 15.7 14.0 18.3 149,777 15.6 13.7 18.7
9 147,874 16.0 14.2 19.0 144,778 16.0 13.9 19.6
10 143,832 16.4 14.4 19.9 141,261 16.4 14.2 20.4
11 142,678 16.8 14.7 20.7 140,371 16.8 14.4 21.3
12 141,210 17.2 15.0 21.6 139,313 17.5 14.8 22.2
13 138,607 17.8 15.3 22.3 137,413 18.3 15.3 23.2
Body surface aread, m2
7 151,893 0.88 0.78 1.02 147,998 0.87 0.76 1.01
8 153,742 0.95 0.83 1.10 149,777 0.94 0.82 1.10
9 147,874 1.02 0.89 1.20 144,778 1.01 0.87 1.20
10 143,832 1.09 0.95 1.29 141,261 1.08 0.93 1.30
11 142,678 1.16 1.01 1.39 140,371 1.16 0.99 1.41
12 141,210 1.24 1.07 1.50 139,313 1.27 1.06 1.54
13 138,607 1.33 1.13 1.63 137,413 1.38 1.15 1.65
a Based on data from the Copenhagen School Health Records Register.
b Numbers of individuals at each age may vary from the total, because not every child had anthropometric values at each age.
c Body mass index was deﬁned as weight (kg)/height (m)2.
d Body surface area was deﬁned as weight (kg)0.5378 × height (cm)0.3964 × 0.024265.
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In the growth analyses of height and MM development,
our results indicated that the risk of MM was 8% higher
among children who were persistently taller, as compared
with children who grew taller between 7 and 13 years of
age. These results indicate that a child’s growth pattern mat-
ters as well, since 2 children at age 13 years will have differ-
ent melanoma risk proﬁles depending on whether they have
been persistently tall or grew tall between 7 and 13 years of
age. Collectively, these results suggest that growth before
age 7 years is of particular importance for MM risk. None of
the previous studies were performed on changes in child-
hood height in relation to future MM risk, and this is most
likely due to the lack of appropriate data resources.
There are putative pathophysiological mechanisms
through which height may affect the subsequent risk of MM.
Studies have identiﬁed genes that are associated with both
height (33) and the underlying processes linked to MM pro-
gression (34–36). Additionally, insulin-like growth factor 1
is positively associated with growth in childhood (37). Inter-
estingly, insulin-like growth factor 1 has been shown to be a
potent growth factor for melanoma cells (38), constituting a
plausible link between greater childhood height and future
melanomagenesis. Moreover, a recent study found a direct
association between the number of melanocytic nevi and
adult height (39), providing another potential explanation for
the height-MM association. Finally, greater height often indi-
cates a higher socioeconomic status (40), providing more
traveling opportunities that could potentially lead to in-
creased sun exposure and MM risk. Nevertheless, the lack of
differences in the associations by birth cohort in this study,
even in the years when charter vacation packages became
popular (41), suggests that the height-MM association occurs
as a result of other factors. Accordingly, it is likely that it is
not height per se but rather a function of underlying height-
regulating mechanisms that eventually drives the malignant
transformation.
Further, we found that birth weight was positively asso-
ciated with the risk of MM. This ﬁnding suggests that accel-
erated growth during fetal life somehow sensitizes children
to MM development in adulthood. Our result is consistent
with an earlier study on this cohort (but with fewer cases)
(8). There are plausible biological links between birth
weight and MM. In humans, the melanocortin 1 receptor
Table 2. Hazard Ratios for the Risk of Adult Malignant Melanoma per Increment of Body Mass Index or Body Surface Area z Score
in Childhood, by Age, Copenhagen, Denmark, 1968–2012a
Age,
years
No. of
Childrenb
No. of
Casesb
Body Mass Indexc Body Surface Aread
Unadjusted Height-Adjustede Unadjusted Height-Adjustede
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
7 299,891 2,194 1.04 1.00, 1.09 1.01 0.96, 1.05 1.19 1.14, 1.24 1.02 0.93, 1.11
8 303,519 2,227 1.05 1.00, 1.10 1.00 0.96, 1.05 1.20 1.15, 1.25 1.01 0.93, 1.10
9 292,652 2,207 1.05 1.00, 1.10 0.99 0.95, 1.04 1.19 1.14, 1.25 0.99 0.91, 1.08
10 285,093 2,176 1.04 1.00, 1.09 0.99 0.94, 1.04 1.18 1.13, 1.24 0.98 0.91, 1.07
11 283,049 2,178 1.03 0.98, 1.08 0.97 0.93, 1.02 1.17 1.12, 1.22 0.96 0.88, 1.04
12 280,523 2,164 1.03 0.98, 1.08 0.97 0.92, 1.02 1.16 1.11, 1.21 0.95 0.87, 1.03
13 276,020 2,144 1.01 0.97, 1.06 0.96 0.91, 1.00 1.14 1.09, 1.19 0.93 0.86, 1.00
Abbreviations: CI, conﬁdence interval; HR, hazard ratio.
a Based on data from the Copenhagen School Health Records Register. All analyses were stratiﬁed by sex and 5-year birth cohort.
b Numbers of individuals at each age may vary from the total, as not every child had anthropometric values at each age.
c Body mass index was deﬁned as weight (kg)/height (m)2.
d Body surface area was deﬁned as weight (kg)0.5378 × height (cm)0.3964 × 0.024265.
e Adjusted for childhood height.
Figure 1. Hazard ratios for the risk of malignant melanoma per incre-
ment of height z score in childhood, unadjusted (•) and adjusted for
body mass index (▾) or body surface area (▪) and stratiﬁed by sex and
5-year birth cohort, Copenhagen, Denmark, 1968–2012. Body mass
index was deﬁned as weight (kg)/height (m)2; body surface area was
deﬁned as weight (kg)0.5378 × height (cm)0.3964 × 0.024265. Based on
data from the Copenhagen School Health Records Register. Bars,
95% conﬁdence intervals.
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gene (MCR1) is highly polymorphic (42). In separate stud-
ies, 2 of its alleles were associated with higher birth weight
(43) and an increased risk of MM (42); thus, it is a potential
pathway linking birth weight and MM.
Our study had several strengths. Because of the unique
CSHRR resource, which has a large population size, and
minimal loss to follow-up, our ﬁndings were not inﬂuenced
by selection bias. Additionally, the inclusion of carefully re-
corded height and weight measurements (in contrast to re-
called and self-reported values) eliminated the inﬂuence of
recall bias on the results. Birth weight was obtained through
parental recall (often supported by written documentation),
and prior studies have found that this is a valid method (44).
The current study may have been limited by the lack of in-
formation on factors that are potentially related to both
childhood body size and MM risk, such as the number of
melanocytic nevi, socioeconomic status, sun exposure his-
tory, and genetic predisposition.
Our ﬁndings are relevant to contemporary populations.
Although there were secular increases in height across the
years included in our study, we did not ﬁnd differences in
the height-MM association by birth cohort, which strength-
ens the plausibility that biological mechanisms underlie the
associations. The Danish population is among the tallest in
the world (45), but since we did not detect nonlinearity in
the height-MM associations, the risk applies across the en-
tire spectrum of height, not just to the tallest children. For
example, our results show that compared with an average-
height 7-year-old boy (123.3 cm; 48.5 inches), a boy who is
5.1 cm (2 inches) taller has a 21% greater risk of MM. The
strength of these associations suggests that height-regulating
processes in childhood could be a target for mechanistic ex-
plorations of MM.
In conclusion, we found that childhood height, indepen-
dently of BMI and BSA, is positively and signiﬁcantly asso-
ciated with the risk of adult MM. In contrast, both childhood
BMI and BSA, adjusted for height, did not play a note-
worthy role in the etiology of adult MM. Furthermore, our
ﬁndings showed that height growth pattern in childhood is
associated with an individual’s predisposition to melanoma-
genesis in adulthood. Finally, we found that a high birth
weight is associated with increased risk of adult MM. Col-
lectively, these results show that height and birth weight
play a role in the origins of MM, thus contributing to the
emerging clariﬁcation of the association between early-life
risk factors and MM development in adulthood.
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